“Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s497. doi:10.25251/skin.8.supp.497.